Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
12.01
-0.28 (-2.24%)
At close: Apr 1, 2025, 4:00 PM
12.48
+0.47 (3.91%)
After-hours: Apr 1, 2025, 6:54 PM EDT

Syndax Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1,0331,1281,8331,7331,1841,048
Upgrade
Market Cap Growth
-38.43%-38.43%5.75%46.42%12.95%339.76%
Upgrade
Enterprise Value
7967231,4611,384969893
Upgrade
Last Close Price
12.0113.2221.6125.4521.8922.24
Upgrade
PE Ratio
----47.49-
Upgrade
PS Ratio
43.4347.65--8.47690.79
Upgrade
PB Ratio
3.573.923.313.712.904.16
Upgrade
P/TBV Ratio
3.923.923.313.712.904.16
Upgrade
P/FCF Ratio
---40.81-
Upgrade
P/OCF Ratio
---40.63-
Upgrade
EV/Sales Ratio
33.6130.53--6.94588.50
Upgrade
EV/EBITDA Ratio
---36.90-
Upgrade
EV/EBIT Ratio
---36.96-
Upgrade
EV/FCF Ratio
---33.42-
Upgrade
Debt / Equity Ratio
1.201.200.000.000.050.08
Upgrade
Debt / EBITDA Ratio
----0.79-
Upgrade
Debt / FCF Ratio
----0.72-
Upgrade
Asset Turnover
0.040.04--0.370.01
Upgrade
Quick Ratio
5.765.769.9616.8121.6215.79
Upgrade
Current Ratio
5.825.8210.0016.8521.6815.84
Upgrade
Return on Equity (ROE)
-75.69%-75.69%-40.98%-34.10%7.55%-51.56%
Upgrade
Return on Assets (ROA)
-31.74%-31.74%-25.89%-20.03%4.37%-24.52%
Upgrade
Return on Capital (ROIC)
-35.69%-35.69%-28.06%-21.13%4.67%-29.25%
Upgrade
Return on Capital Employed (ROCE)
----6.10%-
Upgrade
Earnings Yield
-30.85%-28.25%-11.42%-8.62%2.11%-6.98%
Upgrade
FCF Yield
-26.61%-24.36%-8.76%-7.71%2.45%-6.80%
Upgrade
Buyback Yield / Dilution
-21.67%-21.67%-15.82%-13.31%-29.81%-35.48%
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q